Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Some problems in standardization of fructosamine tests].

S Krantz1, S Lober, M Lober

  • 1Institut für Biochemie, Bereichs Medizin der Ernst-Moritz-Arndt-Universität Greifswald.

Zeitschrift Fur Medizinische Laboratoriumsdiagnostik
|January 1, 1991
PubMed
Summary

Nonenzymatic glycation of serum proteins, measured as fructosamine, requires careful evaluation against protein concentration to avoid misinterpretation in both nondiabetic and Type 2 diabetic patients. Standardizing secondary glycated protein standards is crucial for reliable fructosamine assays in diabetes management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supply chain and marketing of sea grapes, <i>Caulerpa racemosa</i> (Forsskål) J. Agardh (Chlorophyta: Caulerpaceae) in Fiji, Samoa and Tonga.

Journal of applied phycology·2014
Same author

[Card-based age control mechanisms at tobacco vending machines. Effect and consequences].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2010
Same author

Tissue distribution of radioiodinated FAUC113: assessment of a pyrazolo(1,5-a) pyridine based dopamine D4 receptor radioligand candidate.

Nuklearmedizin. Nuclear medicine·2006
Same author

Anemia in the elderly-clinical findings and impact on health.

Critical reviews in oncology/hematology·2006
Same author

[Drug addiction prevention in the workplace--feasibility study in a company from the chemical industry].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2004
Same author

Binding of Amadori glucose-modified albumin by the monocytic cell line MonoMac 6 activates protein kinase C epsilon protein tyrosine kinases and the transcription factors AP-1 and NF-kappaB.

Glycoconjugate journal·2002

Area of Science:

  • Clinical Chemistry
  • Endocrinology
  • Biochemical Analysis

Background:

  • Nonenzymatic glycation of serum proteins is a marker of glycemic control.
  • Accurate measurement of glycated proteins, like fructosamine, is essential for managing diabetes.
  • Variability in standardization can impact clinical interpretation.

Purpose of the Study:

  • To assess the degree of nonenzymatic glycation of serum proteins in nondiabetic and Type 2 diabetic individuals.
  • To evaluate the impact of considering serum protein concentration on fructosamine measurements.
  • To highlight challenges in standardizing glycated protein assays for clinical use.

Main Methods:

  • Estimation of nonenzymatic glycation of serum proteins (fructosamine) in 500 nondiabetic subjects and 124 Type 2 diabetic outpatients.

Related Experiment Videos

  • Evaluation of fructosamine values against a DMF calibration curve, a secondary glycated protein standard, and serum protein concentrations.
  • Analysis of data distribution and potential misinterpretations due to neglecting protein concentration.
  • Main Results:

    • Failing to account for serum protein concentration led to incorrect interpretation of 0.4% of nondiabetic samples and 9% of diabetic samples.
    • Fructosamine values in nondiabetic subjects exhibited a Gaussian distribution.
    • Standardization curves for secondary glycated protein standards showed variability when using DMF protein mixtures, particularly with different albumin preparations.

    Conclusions:

    • Accurate fructosamine assay results necessitate evaluation relative to serum protein concentration to prevent misclassification.
    • The development and validation of reliable secondary glycated protein standards are critical for the widespread adoption of fructosamine assays in diabetes care.
    • Addressing standardization issues with primary standards is essential for consistent and dependable clinical application of fructosamine measurements.